Skip to main navigation Skip to search Skip to main content

Recent Developments in Neurofibromatoses and RASopathies: Management, Diagnosis and Current and Future Therapeutic Avenues

  • Katherine A. Rauen
  • , Susan M. Huson
  • , Emma Burkitt-Wright
  • , D. Gareth Evans
  • , Said Farschtschi
  • , Rosalie E. Ferner
  • , David H. Gutmann
  • , C. Oliver Hanemann
  • , Bronwyn Kerr
  • , Eric Legius
  • , Luis F. Parada
  • , Michael Patton
  • , Juha Peltonen
  • , Nancy Ratner
  • , Vincent M. Riccardi
  • , der Vaart T van
  • , Miikka Vikkula
  • , DH Viskochi
  • , Martin Zenker
  • , Meena Upadhyaya*
  • *Corresponding author for this work
  • University of California at Davis
  • Imperial College Healthcare NHS Trust
  • University of Manchester
  • University of Hamburg
  • Guy's and St Thomas' NHS Foundation Trust
  • Washington University St. Louis
  • KU Leuven
  • University of Texas at Dallas
  • Kingston University and St George’s
  • University of Turku
  • University of Cincinnati
  • The Neurofibromatosis Institute
  • Université catholique de Louvain
  • Otto von Guericke University Magdeburg
  • Cardiff University

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)1-10
Number of pages0
JournalAMERICAN JOURNAL OF MEDICAL GENETICS PART A
Volume167
Issue number1
DOIs
Publication statusPublished - 2015

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • capillary malformation-AV malformation syndrome
  • cardio-facio-cutaneous syndrome
  • Costello syndrome
  • neurofibromatosis
  • Noonan syndrome
  • Legius syndrome
  • Ras/MAPK
  • signal transduction pathway
  • RASopathy
  • therapy

Cite this